Rasagiline Mesylate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Rasagiline Mesylate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Rasagiline Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 16 USDMF, 10 EU WC, 14 KDMF, 11 NDC API, 21 Listed Suppliers, $ API Reference Price

33 API Suppliers
16 USDMF
10 EU WC
14 KDMF
11 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

142 FDF Dossiers, 26 FDA Orange Book, 80 Europe, 8 Canada, 14 Australia, 1 South Africa, 13 Listed Dossiers

142 FDF Dossiers
26 FDA Orange Book
80 Europe
8 Canada
14 Australia
1 South Africa
13 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 1 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 20 Kerry, 8 Microlex e.U, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 20 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Vasa Pharmachem

1 Rochem International Inc
17 SPI Pharma
1 DKSH
4 Faran Shimi Pharmaceutical
5 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
3 BASF
5 DFE Pharma
5 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
4 Ingredion Pharma Solutions
20 Kerry
8 Microlex e.U
1 Pharmatrans-Sanaq
4 Pluviaendo
2 Prachin Chemical
20 Roquette
1 Seppic
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
11 Sigachi Industries
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 26 Direct Compression, 20 Disintegrants & Superdisintegrants, 15 Granulation, 15 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 14 Taste Masking, 12 Thickeners and Stabilizers, 8 Coating Systems & Additives, 7 Lubricants & Glidants, 6 Film Formers & Plasticizers, 5 Controlled & Modified Release, 5 Parenteral, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Solubilizers, 1 Topical

60 Fillers, Diluents & Binders
26 Direct Compression
20 Disintegrants & Superdisintegrants
15 Granulation
15 Chewable & Orodispersible Aids
14 Co-Processed Excipients
14 Taste Masking
12 Thickeners and Stabilizers
8 Coating Systems & Additives
7 Lubricants & Glidants
6 Film Formers & Plasticizers
5 Controlled & Modified Release
5 Parenteral
2 Rheology Modifiers
2 Emulsifying Agents
1 API Stability Enhancers
1 Solubilizers
1 Topical

DIGITAL CONTENT

21 NEWS #PharmaBuzz

21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 69 Finished Drug Prices, 6 Annual Reports

2 US Medicaid Prescriptions
69 Finished Drug Prices
6 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

4 US Patents, 6 Health Canada Patents

4 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 10,368 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Teva Canada Innovation

filter Patent Reset all filters

6 All

01 22031714

02 22174449

03 22232310

filter Product Reset all filters

6 All

01 6Rasagiline mesylate

filter Dosage Reset all filters

6 All

01 3Tablet

02 3tablet

filter Exp Date Reset all filters

6 All

01 22010-12-06

02 22014-10-12

03 22016-09-18

Product Main Page

01

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-12-06

Date Granted : 1998-08-25

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2031714

Filing Date : 1990-12-06

Strength per Unit : 0.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-12-06

Date Granted : 1998-08-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-09-18

Date Granted : 2008-01-08

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2232310

Filing Date : 1996-09-18

Strength per Unit : 0.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-09-18

Date Granted : 2008-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-12

Date Granted : 2007-01-16

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2174449

Filing Date : 1994-10-12

Strength per Unit : 0.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-12

Date Granted : 2007-01-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-12-06

Date Granted : 1998-08-25

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2031714

Filing Date : 1990-12-06

Strength per Unit : 1mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-12-06

Date Granted : 1998-08-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-09-18

Date Granted : 2008-01-08

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2232310

Filing Date : 1996-09-18

Strength per Unit : 1mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-09-18

Date Granted : 2008-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Teva Canada Innovation

Rasagiline Mesylate

BioAsia

Not Confirmed

Teva Canada Innovation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-12

Date Granted : 2007-01-16

Rasagiline Mesylate

Brand Name : AZILECT

Patent Number : 2174449

Filing Date : 1994-10-12

Strength per Unit : 1mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-12

Date Granted : 2007-01-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!